Liver transplantation for metastatic colorectal cancer (case report)-Reference-Cited by-同舟云学术

Liver transplantation for metastatic colorectal cancer (case report)

Published:2019-01-23 Issue:4 Volume:23 Page:54-67
ISSN:2408-9524
Container-title:Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
language:
Short-container-title:Ann. hir. gepatol.

Author:

Porshennikov I. A.¹^ORCID,Sokolov A. V.²,Shchekina E. E.³,Chubukov A. Yu.²,Tretyakova T. A.²,Ostanina I. B.⁴,Kartashov A. S.³,Korobeynikova M. A.³,Yushina E. G.³,Bykov A. Yu.³

Affiliation:

1. State Novosibirsk Regional Clinical Hospital; Novosibirsk State Medical University of Ministry of Health of the Russian Federation

2. City Clinical Hospital No. 1

3. State Novosibirsk Regional Clinical Hospital

4. Novosibirsk Regional Clinical Oncology Centre

Abstract

Liver transplantation is currently controversial for colorectal cancer metastases and not recommended in clinical guidelines. We report the first Russian case of liver transplantation from cadaveric donor in a patient with multiple bilobar unresectable liver metastases of colon cancer. We observe no recurrences within 10 months on everolimus-based immunosuppression and adjuvant treatment. The current state of the problem and the place of liver transplantation in metastatic colorectal cancer treatment are discussed in a short review.

Publisher

Annals of Surgical Hepatology

Subject

Gastroenterology,Hepatology,Surgery

Reference44 articles.

1. Zlokachestvennye novoobrazovaniya v Rossii v 2017 godu. [Malignancies in Russia in 2017]. Kaprin A.D., Starinsky V.V., Petrova G.V., Eds. Moscow: P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, 2018. 250 p. (In Russian)

2. Kanas G.P., Taylor A., Primrose J.N., Langeberg W.J., Kelsh M.A., Mowat F.S., Alexander D.D., Choti M.A., Poston G. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin. Epidemiol. 2012; 4: 283-301. DOI: 10.2147/CLEP.S34285.

3. Mody K., Baldeo C., Bekaii-Saab T. Antiangiogenic therapy in colorectal cancer. Cancer J. 2018; 24 (4): 165-170. DOI: 10.1097/PPO.0000000000000328.

4. Hecht J.R., Mitchell E., Chidiac T., Scroggin C., Hagenstad C., Spigel D., Marshall J., Cohn A., McCollum D., Stella P., Deeter R., Shahin S., Amado R.G. A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer. J. Clin. Oncol. 2009; 27 (5): 672-680. DOI: 10.1200/JCO.2008.19.8135.

5. Bennouna J., Sastre J., Arnold D., Osterlund P., Greil R., Van Cutsem E., von Moos R., Vieitez J.M., Bouche O., Borg C., Steffens C.C., Alonso-Orduna V., Schlichting C., Reyes-Rivera I., Bendahmane B., Andre T., Kubicka S.; ML18147 Study Investigators. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial. Lancet Oncol. 2013; 14 (1): 29-37. DOI: 10.1016/S1470-2045(12)70477-1.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors in deceased donor liver transplantation: a single centre experience;Russian Journal of Transplantology and Artificial Organs;2022-10-04

2. Colorectal cancer liver metastases: current state of the problem, priority treatment approaches;Khirurgiya. Zhurnal im. N.I. Pirogova;2022

3. Colorectal liver metastases: global trends in epidemiology, modern opportunities for treatment;Onkologiya. Zhurnal imeni P.A.Gertsena;2021